Guardant Health announced that its Infinityai real-world evidence research data has successfully supported the regulatory approval of the targeted drug Enhertu® in Japan for the treatment of patients with previously treated HER2-positive metastatic solid tumors.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This development marks further validation of the important value of real-world evidence in accelerating the approval process for innovative therapies.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$68,553.85
-4.29%
Ethereum
ETH
$1,925.15
-3.93%
Tether USDt
USDT
$0.9992
+0.02%
BNB
BNB
$631.49
-3.64%
USDC
USDC
$0.9997
-0.00%
XRP
XRP
$1.02
-0.33%
Solana
SOL
$79.59
-1.91%
TRON
TRX
$0.3131
-0.86%
Hyperliquid
HYPE
$72.26
+2.06%
Zcash
ZEC
$944.43
-0.31%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now